GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor

E-ISSN： 1875-533x|17|14|1411-1429

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.14, 2010-05, pp. : 1411-1429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-06 ,pp. : 799-813

Bentham Science Publishers

Access to resources Recommend Favorite

The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-04 ,pp. : 482-503

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer-Type Organic Anion Transporting Polypeptide 1B3: Current Knowledge of the Gene Structure, Expression Profile, Functional Implications and Future Perspectives

Current Drug Metabolism, Vol. 16, Iss. 6, 2015-07 ,pp. : 474-485

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory Biomarkers and Cardiovascular Risk Assessment. Current Knowledge and Future Perspectives

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3827-3840

Bentham Science Publishers

Access to resources Recommend Favorite

The Cellular Pharmacokinetics of HIV Protease Inhibitors: Current Knowledge and Future Perspectives

Current Drug Metabolism, Vol. 13, Iss. 8, 2012-10 ,pp. : 1174-1183

Bentham Science Publishers

Access to resources Recommend Favorite